Detalhe da pesquisa
1.
Clinical outcome of low-risk differentiated thyroid cancer patients after radioiodine remnant ablation and recombinant human thyroid-stimulating hormone preparation.
Clin Oncol (R Coll Radiol)
; 24(3): 162-8, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21411300